Eko Analysis Software vs HeartFlow Analysis

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Eko Health
VS
by Heartflow

AI Verdict

Tool A (Eko Analysis Software) is designed for the early detection of cardiovascular conditions like heart murmurs and atrial fibrillation using digital stethoscopes and ECGs. In contrast, Tool B (HeartFlow Analysis) focuses on the non-invasive diagnosis and management of coronary artery disease through AI-powered 3D modeling of coronary arteries from CT scans. While both are cardiology AI tools, they serve different diagnostic purposes and utilize distinct data inputs, making them adjacent rather than direct competitors.

Choose Eko Analysis Software if…

Choose Eko Analysis Software if you need an accessible, real-time AI-powered tool for early detection of common cardiovascular conditions like heart murmurs and atrial fibrillation during routine physical exams or telehealth consultations. This solution is ideal for clinicians seeking to augment their auscultation skills with immediate AI insights and securely record heart sounds and ECGs at the point of care.

View Eko Analysis Software →

Choose HeartFlow Analysis if…

Choose HeartFlow Analysis if you require a non-invasive, advanced diagnostic solution for patients with suspected coronary artery disease, leveraging AI to create personalized 3D models from standard CT scans. This tool is best suited for cardiologists and radiologists who need detailed functional and anatomical insights, such as Fractional Flow Reserve derived from CT (FFRct) and plaque analysis, to guide treatment decisions and potentially avoid unnecessary invasive procedures.

View HeartFlow Analysis →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Eko Analysis Software HeartFlow Analysis
Pricing Unknown Contact vendor for pricing
Deployment Unknown Cloud-based (AWS)
BAA Available Yes AI-estimated Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Eko Analysis Software

Eko Analysis Software offers a more broadly accessible and intuitive user experience due to its integration with digital stethoscopes and a mobile app, enabling real-time, point-of-care screening. Its freemium model also lowers the barrier to entry for individual clinicians.

Clinical Value

HeartFlow Analysis

HeartFlow Analysis provides a higher clinical value by offering a non-invasive functional assessment of coronary artery disease (CAD) through FFRct and plaque analysis, which can significantly impact definitive treatment planning and potentially replace invasive procedures. It is backed by extensive clinical evidence.

Pricing & Value

Eko Analysis Software

Eko Analysis Software offers superior pricing transparency and immediate value, with its core AI detection features for heart murmurs and AFib now available at no charge via the mobile app. While HeartFlow has strong reimbursement with established CPT codes, its 'contact vendor' pricing lacks initial transparency.

Enterprise Readiness

HeartFlow Analysis

HeartFlow Analysis demonstrates stronger enterprise readiness through its comprehensive support for technology integration with PACS/EMR, established CPT codes, and robust billing and reimbursement assistance, indicating a design for seamless integration into large hospital systems and existing workflows.

Innovation

HeartFlow Analysis

HeartFlow Analysis is more innovative due to its use of AI and computational fluid dynamics to non-invasively derive fractional flow reserve from CT (FFRct) for functional assessment of CAD. This represents a significant technological advancement that can reduce the need for invasive procedures.

Support & Docs

Tie

Both tools offer robust support and documentation tailored to their respective user bases. Eko provides extensive resources through its help center, FAQs, user manuals, and direct contact options for individual and enterprise users, while HeartFlow offers comprehensive enterprise-level support covering technical integration, billing, and clinical guidance.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Eko Analysis Software HeartFlow Analysis
Tool Name Eko Analysis Software HeartFlow Analysis
Company Eko Devices HeartFlow
Primary Purpose FDA-cleared AI-powered tool that integrates with Eko's digital stethoscopes and mobile app to assist clinicians in the early detection of cardiovascular diseases like heart murmurs and atrial fibrillation. Software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease (CAD) by creating personalized 3D models of patients' coronary arteries from standard CT scans.
Key AI Functionality FDA-cleared AI for heart murmur detection; FDA-cleared AI for atrial fibrillation (AFib) detection; Detection of normal sinus rhythm. AI-powered 3D modeling of coronary arteries; Fractional Flow Reserve derived from CT (FFRct) analysis; Plaque Analysis (quantification and characterization).
Specialties Cardiology, Emergency Medicine, Internal Medicine Cardiology, Radiology
Diagnostic Output/Insights Visualization of phonocardiograms (PCG) and ECG tracings; Calculation of cardiac time intervals (heart rate, QRS duration); Secure cloud-based storage of recordings within the US. Personalized 3D models of coronary arteries; FFRct analysis; Plaque Analysis; Roadmapu2122 Analysis for CCTA reading; Computational Fluid Dynamics (CFD) for blood flow simulation.

Videos

Demos, reviews, and walkthroughs featuring Eko Analysis Software and HeartFlow Analysis.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Eko Analysis Software is an FDA-cleared AI-powered tool that assists clinicians in the early detection of cardiovascular diseases like heart murmurs and atrial fibrillation. HeartFlow Analysis is designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease (CAD) by creating personalized 3D models of patients' coronary arteries from standard CT scans.
Eko Analysis Software integrates with Eko's digital stethoscopes and mobile app to analyze simultaneous heart sounds (phonocardiograms) and ECGs. HeartFlow Analysis processes previously acquired Computed Tomography (CT) DICOM data to create personalized 3D models of coronary arteries and simulate blood flow.
Eko Analysis Software is primarily used across Cardiology, Emergency Medicine, and Internal Medicine. HeartFlow Analysis is mainly utilized within Cardiology and Radiology specialties.
Eko Analysis Software offers FDA-cleared AI for heart murmur detection, atrial fibrillation (AFib) detection, and normal sinus rhythm detection, along with calculating cardiac time intervals. HeartFlow Analysis provides AI-powered 3D modeling of coronary arteries, Fractional Flow Reserve derived from CT (FFRct) analysis, and Plaque Analysis (quantification and characterization).

Backers

Who funded each tool's parent company.

Eko Analysis Software

HeartFlow Analysis

AI Tool Finder
AI-powered search. Results may not be comprehensive.